PT - JOURNAL ARTICLE AU - Goldhaber-Fiebert, Jeremy D. AU - Prince, Lea AU - Chin, Elizabeth T. AU - Leidner, David AU - Studdert, David M. AU - Salomon, Joshua A. AU - Andrews, Jason R. TI - Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations AID - 10.1101/2022.01.21.22269664 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.21.22269664 4099 - http://medrxiv.org/content/early/2022/01/23/2022.01.21.22269664.short 4100 - http://medrxiv.org/content/early/2022/01/23/2022.01.21.22269664.full AB - To distinguish waning of vaccine responses from differential variant protection, we performed a test-negative case-control analysis during a Delta variant-dominant period in California’s prisons. We found that infection odds increased each 28-day period post-vaccination, reaching 3.4-fold (residents) to 4.7-fold (staff) increased odds of infection after 180 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported in part by the Covid-19 Emergency Response Fund at Stanford, established with a gift from the Horowitz Family Foundation; a grant (R37-DA15612), awarded to Dr. Goldhaber-Fiebert and Dr. Salomon, from the National Institute on Drug Abuse; a grant (NU38OT000297-02), awarded to Dr. Salomon, from the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists; a grant (DGE-1656518), awarded to Ms. Chin, from the National Science Foundation Graduate Research Fellowship Program. The funders had no role in the study's design, conduct, or reporting, or in the publication decision. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford Institution Review Board (Protocol: IRB-55835)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were shared by the California Department of Corrections and Rehabilitation under a Data Use Agreement and hence are not available.